HT CAPITAL

ht-capital-logo

HT Capital, an establishment under Hongtao (HT) Asset Management has been actively investing since 1999. The management team, based between Beijing and Hong Kong covers a full-spectrum of investment activities and strategic portfolio managements in varies sectors including Healthcare, IT and the TMT industry.

#Financial #More

HT CAPITAL

Status:
Active


Investments List

Date Company Article Money raised
2022-01-03 Kula Bio HT Capital investment in Series A - Kula Bio 50 M USD
2021-09-13 Alebund Pharmaceuticals HT Capital investment in Series B - Alebund Pharmaceuticals 54.5 M USD
2021-08-01 JOINN Biologics HT Capital investment in Series B - JOINN Biologics 150 M USD
2021-06-01 Inmagene Biopharmaceuticals HT Capital investment in Series C - Inmagene Biopharmaceuticals 100 M USD
2020-09-25 LeJian HT Capital investment in Series A - LeJian N/A
2020-09-09 LandSpace HT Capital investment in Series C - LandSpace 1.2 B CNY
2020-04-04 Kringle Pharma HT Capital investment in Venture Round - Kringle Pharma 740 M JPY
2019-07-19 TriArm Therapeutics HT Capital investment in Series A - TriArm Therapeutics 20 M USD
2019-05-27 Kyulux HT Capital investment in Series B - Kyulux 3.5 B JPY
2018-10-25 XtalPi HT Capital investment in Series B - XtalPi 46 M USD

More informations about "HT Capital" on Search Engine